ID

34161

Descrizione

Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232); ODM derived from: https://clinicaltrials.gov/show/NCT01881932

collegamento

https://clinicaltrials.gov/show/NCT01881932

Keywords

  1. 14/01/19 14/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

14 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT01881932

Eligibility Breast Cancer NCT01881932

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven stage i-iii carcinoma of the breast or histologically proven stage i-iii colorectal carcinoma.
Descrizione

ID.1

Tipo di dati

boolean

receiving adjuvant or neoadjuvant chemotherapy that includes a taxane or oxaliplatin.
Descrizione

ID.2

Tipo di dati

boolean

while on chemotherapy, develop greater than or equal to nci-ctc grade 2 cipn.
Descrizione

ID.3

Tipo di dati

boolean

eastern cooperative oncology group performance status 0-2.
Descrizione

ID.4

Tipo di dati

boolean

the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
Descrizione

ID.5

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior acupuncture within one year of enrollment.
Descrizione

ID.6

Tipo di dati

boolean

known metastatic (stage iv) breast or colorectal cancer involvement.
Descrizione

ID.7

Tipo di dati

boolean

pre-existing peripheral neuropathy before chemotherapy is initiated
Descrizione

ID.8

Tipo di dati

boolean

currently taking anti-neuropathy medication such as gabapentin, or pregabalin.
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Breast Cancer NCT01881932

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically proven stage i-iii carcinoma of the breast or histologically proven stage i-iii colorectal carcinoma.
boolean
ID.2
Item
receiving adjuvant or neoadjuvant chemotherapy that includes a taxane or oxaliplatin.
boolean
ID.3
Item
while on chemotherapy, develop greater than or equal to nci-ctc grade 2 cipn.
boolean
ID.4
Item
eastern cooperative oncology group performance status 0-2.
boolean
ID.5
Item
the patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
prior acupuncture within one year of enrollment.
boolean
ID.7
Item
known metastatic (stage iv) breast or colorectal cancer involvement.
boolean
ID.8
Item
pre-existing peripheral neuropathy before chemotherapy is initiated
boolean
ID.9
Item
currently taking anti-neuropathy medication such as gabapentin, or pregabalin.
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial